Working to facilitate rapid translation of scientific discoveries into therapeutics

Cornelia Kasper

cornelia kasper cutted

Cornelia Kasper, PhD

Cornelia Kasper studied Chemistry at the University Hannover and received her Diploma degree 1994. She performed her PhD thesis at the Institute for Technical Chemistry 1995-1998 on: “Purification of proteins and other biological active compounds using novel chromatographic approaches”. She was employed as EU liason officer at the University of Hannover 1998-2000. Afterwards she returned to science and teaching and received a Habilitation-fellowship from the University of Hannover 2000-2006. She finished her Habilitation on “New approaches in cell culture techniques”and received the Venia legendi “Technische Chemie” in 2007. 2000-2011 Cornelia Kasper has been head of Cell Culture and Tissue Engineering Group at the Institute for Technical Chemistry, Leibniz University of Hannover. Her research focus: cell culture technology, Tissue Engineering, design and development of bioreactors and optimization of process technology, functionalization and testing of biomaterials for Tissue Engineering application, development of procedures for stem cell isolation, characterization, expansion and differentiation. Furthermore she was head of young researcher group JRG “Large Scale Cultivation” within Cluster of Excellence “Rebirth” (from Regenerative Biology and Reconstructive Therapies). Since October 2011 Cornelia Kasper has been appointed as University Professor “Biopharmaceutical Technology and Products” at the Department of Biotechnology at Boku. She has published more than 130 papers in reputed journals and several book chapters and is editor within the series “Advances in Biochemical Engineering and Biotechnology” (Springer) of several volumes covering actual areas in Tissue Engineering and Stem Cell Research. She is also reviewer for many distinguished journal within the field of biotechnology / bioprocess and bioreactor design and enabling technologies for stem cell cultivation and expert reviewer for national and international funding agencies.

2013-2021©European Society for Translational Medicine (EUSTM)